A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

KDNY Insider Trading (Chinook Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.38%

Insider Buying (Last 12 Months): $19,679,160.00

Insider Selling (Last 12 Months): $45,944,992.50

Chinook Therapeutics Insider Trading History Chart

Chinook Therapeutics Share Price & Price History

^$21.01

▲ +0.37 (1.79%)

As of 08/15/2022 06:19 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Chinook Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/4/2022	Andrew James King	Insider	Sell	5,000	$20.00	$100,000.00	5,897
7/11/2022	Andrew James King	Insider	Sell	5,000	$18.09	$90,450.00	5,897
5/25/2022	Eric Dobmeier	CEO	Buy	5,000	$13.03	$65,150.00	205,880
4/11/2022	Andrew James King	Insider	Sell	5,000	$15.36	$76,800.00	5,897
2/18/2022	Andrew James King	Insider	Sell	2,500	$13.00	$32,500.00
2/11/2022	Eric Bjerkholt	CFO	Sell	895	$12.74	$11,402.30
2/11/2022	Tom Frohlich	COO	Sell	3,735	$12.74	$47,583.90
2/10/2022	Andrew James King	Insider	Sell	2,500	$13.31	$33,275.00
1/3/2022	Jerel Davis	Director	Sell	1,000,000	$16.00	$16,000,000.00
1/3/2022	Versant Venture Capital Vii, L	Major Shareholder	Sell	600,000	$16.00	$9,600,000.00
11/15/2021	Srinivas Akkaraju	Director	Buy	1,215,000	$14.00	$17,010,000.00
11/10/2021	Tom Frohlich	COO	Sell	6,230	$15.48	$96,440.40
11/9/2021	Andrew James King	Insider	Sell	5,000	$13.53	$67,650.00
11/8/2021	Tom Frohlich	COO	Sell	13,770	$15.17	$208,890.90
11/5/2021	Tom Frohlich	COO	Sell	20,000	$14.00	$280,000.00
9/24/2021	Tom Frohlich	COO	Sell	20,000	$13.00	$260,000.00
9/20/2021	Eric Dobmeier	CEO	Buy	2,000	$12.00	$24,000.00
8/27/2021	Jerel Davis	Director	Sell	850,000	$14.00	$11,900,000.00
8/27/2021	Versant Venture Capital Vii, L	Major Shareholder	Sell	510,000	$14.00	$7,140,000.00
8/18/2021	Eric Dobmeier	CEO	Buy	7,000	$11.74	$82,180.00
8/18/2021	Srinivas Akkaraju	Director	Buy	208,500	$11.98	$2,497,830.00
6/16/2021	Alan Glicklich	Insider	Sell	20,000	$16.35	$327,000.00	20,000
5/14/2021	Eric Dobmeier	CEO	Buy	1,000	$14.44	$14,440.00
12/8/2020	Eric Dobmeier	CEO	Buy	2,000	$13.24	$26,480.00
11/23/2020	Eric Dobmeier	CEO	Buy	929	$13.67	$12,699.43
11/19/2020	Eric Dobmeier	CEO	Buy	500	$13.50	$6,750.00
11/10/2020	Eric Dobmeier	CEO	Buy	2,000	$13.86	$27,720.00

The ONLY Way to Play Markets Like These

From Oxford Club | Ad

The best investor in the world knows the only way to prosper (especially in markets like these)... is to invest in VALUE. But this $2 stock could be the last value play in the market today.

See Why This $2 Stock Could Be $50 and STILL Be a Bargain.

Click here.

SEC Filings (Institutional Ownership Changes) for Chinook Therapeutics (NASDAQ:KDNY)

84.23% of Chinook Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Chinook Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2022	Laurion Capital Management LP	829,750	$14.51M	0.2%	+9.9%	1.504%
8/15/2022	Millennium Management LLC	1,185,233	$20.73M	0.0%	+60.8%	2.148%
8/15/2022	Sei Investments Co.	23,379	$0.41M	0.0%	N/A	0.042%
8/15/2022	UBS Asset Management Americas Inc.	15,109	$0.26M	0.0%	N/A	0.027%
8/13/2022	Quantbot Technologies LP	3,471	$60K	0.0%	N/A	0.006%
8/13/2022	Renaissance Technologies LLC	272,962	$4.77M	0.0%	+2.3%	0.495%
8/13/2022	C M Bidwell & Associates Ltd.	9,290	$0.16M	0.1%	N/A	0.017%
8/12/2022	Northern Trust Corp	388,507	$6.80M	0.0%	+10.9%	0.704%
8/12/2022	Virtus ETF Advisers LLC	6,441	$0.11M	0.0%	-38.9%	0.012%
8/12/2022	Affinity Asset Advisors LLC	937,568	$16.40M	6.9%	+10.9%	1.699%
8/12/2022	Credit Suisse AG	26,732	$0.47M	0.0%	N/A	0.048%
8/12/2022	ClariVest Asset Management LLC	31,556	$0.55M	0.0%	N/A	0.057%
8/12/2022	Rafferty Asset Management LLC	39,302	$0.69M	0.0%	-50.5%	0.071%
8/12/2022	FMR LLC	354,834	$6.21M	0.0%	-37.7%	0.643%
8/12/2022	Rhumbline Advisers	63,397	$1.11M	0.0%	+26.3%	0.115%
8/11/2022	UBS Group AG	14,126	$0.25M	0.0%	-81.0%	0.026%
8/11/2022	Martingale Asset Management L P	41,217	$0.72M	0.0%	+3.3%	0.075%
8/11/2022	Alps Advisors Inc.	36,508	$0.64M	0.0%	-32.8%	0.066%
8/11/2022	JPMorgan Chase & Co.	131,876	$2.31M	0.0%	-1.0%	0.239%
8/10/2022	Frazier Life Sciences Management L.P.	3,595,026	$62.88M	5.9%	+32.6%	6.515%
8/10/2022	Principal Financial Group Inc.	21,512	$0.38M	0.0%	N/A	0.039%
8/9/2022	Swiss National Bank	93,500	$1.64M	0.0%	N/A	0.169%
8/9/2022	Shell Asset Management Co.	7,616	$0.13M	0.0%	N/A	0.014%
8/8/2022	Walleye Capital LLC	276,538	$4.84M	0.1%	+59.4%	0.501%
8/8/2022	Baillie Gifford & Co.	504,825	$8.83M	0.0%	-37.7%	0.915%
8/5/2022	State Board of Administration of Florida Retirement System	12,960	$0.23M	0.0%	N/A	0.023%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	120,942	$2.12M	0.0%	+362.5%	0.219%
8/3/2022	Candriam S.C.A.	871,155	$15.24M	0.1%	-26.5%	1.579%
7/29/2022	SG Americas Securities LLC	24,266	$0.42M	0.0%	N/A	0.044%
7/28/2022	Arizona State Retirement System	10,761	$0.19M	0.0%	N/A	0.020%
7/27/2022	Assenagon Asset Management S.A.	1,061,882	$18.57M	0.1%	N/A	1.924%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	13,134	$0.23M	0.0%	N/A	0.024%
7/25/2022	Strs Ohio	4,100	$71K	0.0%	N/A	0.007%
7/15/2022	Marquette Asset Management LLC	38,000	$0.67M	0.2%	+7.0%	0.069%
6/30/2022	Amalgamated Bank	4,705	$77K	0.0%	N/A	0.009%
6/7/2022	Bank of America Corp DE	66,123	$1.08M	0.0%	-69.6%	0.120%
5/27/2022	Walleye Capital LLC	173,503	$2.84M	0.1%	-1.7%	0.314%
5/20/2022	International Biotechnology Trust PLC	340,389	$4.71M	1.1%	+17.6%	0.617%
5/17/2022	Walleye Capital LLC	173,503	$2.84M	0.1%	-1.7%	0.314%
5/17/2022	Royal Bank of Canada	2,478	$41K	0.0%	-66.8%	0.004%
5/17/2022	Rock Springs Capital Management LP	700,349	$11.46M	0.3%	-2.8%	1.269%
5/17/2022	Great Point Partners LLC	1,423,682	$23.29M	5.6%	+265.0%	2.580%
5/16/2022	California State Teachers Retirement System	17,241	$0.28M	0.0%	-19.1%	0.031%
5/16/2022	Goldman Sachs Group Inc.	234,738	$3.84M	0.0%	+7.6%	0.427%
5/16/2022	Wellington Management Group LLP	46,416	$0.76M	0.0%	N/A	0.084%
5/16/2022	Deep Track Capital LP	3,000,000	$49.08M	3.1%	+23.9%	5.459%
5/16/2022	State Street Corp	1,597,002	$26.13M	0.0%	+24.0%	2.906%
5/16/2022	Suvretta Capital Management LLC	1,434,200	$23.46M	0.7%	+15.0%	2.610%
5/16/2022	Frazier Life Sciences Management L.P.	2,712,041	$44.37M	3.8%	N/A	4.935%
5/16/2022	Invesco Ltd.	30,899	$0.51M	0.0%	+179.7%	0.056%
5/16/2022	UBS Group AG	74,414	$1.22M	0.0%	+65.3%	0.135%
5/13/2022	Renaissance Technologies LLC	266,742	$4.36M	0.0%	-27.6%	0.485%
5/13/2022	Northern Trust Corp	350,290	$5.73M	0.0%	+0.6%	0.637%
5/13/2022	Charles Schwab Investment Management Inc.	111,475	$1.82M	0.0%	+9.2%	0.203%
5/13/2022	Lazard Asset Management LLC	4,700	$76K	0.0%	N/A	0.009%
5/13/2022	Affinity Asset Advisors LLC	845,155	$13.83M	2.2%	+52.2%	1.538%
5/13/2022	American International Group Inc.	20,029	$0.33M	0.0%	-3.5%	0.036%
5/13/2022	Candriam Luxembourg S.C.A.	1,185,314	$19.39M	0.1%	+7.3%	2.157%
5/13/2022	Vanguard Group Inc.	1,829,372	$29.93M	0.0%	+2.4%	3.329%
5/13/2022	Dimensional Fund Advisors LP	520,475	$8.52M	0.0%	+78.3%	0.947%
5/12/2022	BlackRock Inc.	3,054,997	$49.98M	0.0%	+2.2%	5.559%
5/12/2022	Rhumbline Advisers	50,184	$0.82M	0.0%	+9.5%	0.091%
5/12/2022	Metropolitan Life Insurance Co NY	2,261	$37K	0.0%	-76.4%	0.004%
5/12/2022	MetLife Investment Management LLC	19,839	$0.33M	0.0%	+58.5%	0.036%
5/12/2022	Martingale Asset Management L P	39,917	$0.65M	0.0%	+42.5%	0.073%
5/12/2022	Monashee Investment Management LLC	90,000	$1.47M	0.4%	-5.3%	0.164%
5/12/2022	Citigroup Inc.	14,840	$0.24M	0.0%	-75.2%	0.027%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	26,147	$0.43M	0.0%	+29.0%	0.048%
5/11/2022	Bank of New York Mellon Corp	153,310	$2.51M	0.0%	+8.3%	0.279%
5/11/2022	JPMorgan Chase & Co.	133,150	$2.18M	0.0%	+2.3%	0.242%
5/10/2022	Nicholas Investment Partners LP	139,818	$2.29M	0.2%	N/A	0.254%
5/10/2022	ProShare Advisors LLC	13,041	$0.21M	0.0%	-18.4%	0.024%
5/5/2022	Baillie Gifford & Co.	810,879	$13.27M	0.0%	-3.9%	1.476%
5/5/2022	New York State Common Retirement Fund	30,448	$0.50M	0.0%	+17.8%	0.055%
5/5/2022	Russell Investments Group Ltd.	15,391	$0.25M	0.0%	-13.8%	0.028%
4/28/2022	DekaBank Deutsche Girozentrale	11,300	$0.19M	0.0%	+9.7%	0.021%
4/26/2022	Marquette Asset Management LLC	35,500	$0.58M	0.1%	+84.5%	0.065%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	1,923	$31K	0.0%	N/A	0.003%
3/3/2022	Walleye Capital LLC	176,551	$2.88M	0.1%	N/A	0.392%
2/18/2022	TCG Crossover Management LLC	882,353	$14.39M	6.7%	N/A	1.958%
2/15/2022	Samsara BioCapital LLC	4,591,888	$74.89M	14.5%	+36.0%	10.188%
2/15/2022	Laurion Capital Management LP	554,250	$9.04M	0.1%	N/A	1.230%
2/14/2022	Virtus ETF Advisers LLC	11,158	$0.18M	0.1%	-11.7%	0.025%
2/14/2022	Altium Capital Management LP	545,000	$8.89M	2.5%	+17.2%	1.209%
2/14/2022	Point72 Asset Management L.P.	2,351,743	$38.36M	0.2%	+136.4%	5.218%
2/14/2022	Suvretta Capital Management LLC	1,247,468	$20.35M	0.4%	+19.1%	2.768%
2/14/2022	Deep Track Capital LP	2,420,502	$39.48M	2.8%	N/A	5.370%
2/14/2022	Soleus Capital Management L.P.	298,700	$4.87M	0.5%	N/A	0.663%
2/14/2022	Maven Securities LTD	28,269	$0.46M	0.0%	N/A	0.063%
2/14/2022	Blair William & Co. IL	10,728	$0.18M	0.0%	-50.4%	0.024%
2/14/2022	ClariVest Asset Management LLC	52,657	$0.86M	0.0%	-1.7%	0.117%
2/14/2022	GSA Capital Partners LLP	14,383	$0.24M	0.0%	N/A	0.032%
2/14/2022	Affinity Asset Advisors LLC	555,155	$9.06M	3.3%	+646.8%	1.232%
2/11/2022	Renaissance Technologies LLC	368,642	$6.01M	0.0%	-30.6%	0.818%
2/10/2022	Candriam Luxembourg S.C.A.	1,104,902	$18.02M	0.1%	+22.4%	2.451%
2/10/2022	Rafferty Asset Management LLC	65,364	$1.07M	0.0%	+41.6%	0.145%
2/10/2022	Citigroup Inc.	59,841	$0.98M	0.0%	+71.5%	0.133%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	20,266	$0.33M	0.0%	N/A	0.045%
2/9/2022	Alps Advisors Inc.	61,221	$1M	0.0%	+11.5%	0.136%
2/9/2022	Dimensional Fund Advisors LP	291,835	$4.76M	0.0%	+41.8%	0.647%

Data available starting January 2016

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.

Today's Range

Now: $21.01

$20.31

$21.06

50 Day Range

MA: $18.40

$15.71

$20.64

52 Week Range

Now: $21.01

$10.48

$21.11

Volume

562,667 shs

Average Volume

489,613 shs

Market Capitalization

$1.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.03

Who are the company insiders with the largest holdings of Chinook Therapeutics?: Chinook Therapeutics' top insider shareholders include:
Eric Dobmeier (CEO)
Alan Glicklich (Insider)
Andrew James King (Insider)
Davis Jerel (Director)
Eric Bjerkholt (CFO)
Srinivas Akkaraju (Director)
Tom Frohlich (COO)
Versant Venture Capital Vii, L (Major Shareholder)
Learn More about top insider investors at Chinook Therapeutics.
Who are the major institutional investors of Chinook Therapeutics?: Chinook Therapeutics' top institutional investors include:
Frazier Life Sciences Management L.P. — 6.52%
Millennium Management LLC — 2.15%
Assenagon Asset Management S.A. — 1.92%
Affinity Asset Advisors LLC — 1.70%
Candriam S.C.A. — 1.58%
Laurion Capital Management LP — 1.50%
Learn More about top institutional investors of Chinook Therapeutics stock.
Which major investors are selling Chinook Therapeutics stock?: In the previous quarter, KDNY stock was sold by these institutional investors:
Candriam S.C.A.
Baillie Gifford & Co.
FMR LLC
UBS Group AG
Rafferty Asset Management LLC
Alps Advisors Inc.
Virtus ETF Advisers LLC
JPMorgan Chase & Co.
In the last year, company insiders that have sold Chinook Therapeutics company stock include:
Eric Dobmeier (CEO)
Alan Glicklich (Insider)
Andrew James King (Insider)
Davis Jerel (Director)
Eric Bjerkholt (CFO)
Learn More investors selling Chinook Therapeutics stock.
Which major investors are buying Chinook Therapeutics stock?: Within the previous quarter, KDNY stock was purchased by institutional investors including:
Assenagon Asset Management S.A.
Frazier Life Sciences Management L.P.
Millennium Management LLC
Walleye Capital LLC
Connor Clark & Lunn Investment Management Ltd.
Swiss National Bank
Affinity Asset Advisors LLC
Laurion Capital Management LP
Within the previous year, these company insiders have bought Chinook Therapeutics stock:
Eric Dobmeier (CEO)
Alan Glicklich (Insider)
Learn More investors buying Chinook Therapeutics stock.

WARNING: Do You Invest with these Banks

From Behind the Markets | Ad

Take a close look at these investment banks. Because if you own stocks with any of these brokerages...

This new political development WILL affect you.

If you invest with any of these brokerage firms, click here to see how to protect your portfolio from this new conflict.

>>>